Bizzell Partners With CDC to Assist in Unintentional Injury Prevention Initiatives
The Bizzell Group (Bizzell) is pleased to kick off the new year with a new opportunity with the Centers of Disease Control and Prevention’s (CDC), National Center for Injury Prevention and Control (NCIPC), Division of Unintentional Injury Prevention (DUIP).
Unintentional injuries, such as falls, car accidents and drug overdoses, are the number three cause of deaths in the United States, and they account for one of every four people treated in an emergency department. Bizzell has an extensive portfolio of supporting injury prevention initiatives related to roadway safety and substance abuse prevention. Therefore, the firm brings a deep working knowledge and understanding to CDC’s injury prevention objectives.
Bizzell’s commitment will include scientific injury prevention consulting, assistance and support services within DUIP. This includes assisting with the preparation of reports, presentations and papers for publication in scientific journals. The firm will identify evidence-based strategies for states to use in preventing injuries, as well as work directly with CDC scientists to exchange ideas on DUIP products that are related to concussions, global traffic injury and falls prevention. Additionally, Bizzell will focus on preparing summary documents for the Office of Global Health on DUIP’s motor vehicle projects, and provide expertise on the development and evaluation of injury modules for the Field Epidemiology Training Program (FETP) in the Center for Global Health.
“Injuries and violence affect everyone, regardless of age, race or economic status. And in the first half of life, more Americans die from violence and injuries than any other cause,” stated Chad Brown, Vice President of Strategy and Business Development for Bizzell. “Bizzell is pleased to offer its expertise and support to CDC in order to collectively develop innovations and solutions as we look to promote improved health and mortality outcomes.”
Bizzell looks forward to its continued partnership with CDC.